Trials / Completed
CompletedNCT00000281
Pharmacotherapy for Schizophrenic Drug Users - 6
Pharmacotherapy for Schizophrenic Drug Users
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate maintenance neuroleptics for Schizophrenic patients who are cocaine abusers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Amantadine |
Timeline
- Start date
- 1994-09-01
- Primary completion
- 1999-08-01
- Completion
- 1999-08-01
- First posted
- 1999-09-21
- Last updated
- 2016-12-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000281. Inclusion in this directory is not an endorsement.